Markers of angiogenesis in serum are correlating with disease progress in lung cancer Source: Annual Congress 2006 - Prognostic factors in lung cancer Year: 2006
Are Vitamin D receptor genetic polymorphisms associated with chemotherapy response and prognosis in patients with advanced non-small-cell lung cancer? Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016
Serum osteopontin as a prognostic marker in patients with lung cancer Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015
Are serum leptin levels a prognostic factor in advanced lung cancer? Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015
Epidemiology of lung cancer Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=1 Year: 2001
Predictors of major serious manifestations in the terminal stage of lung cancer Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005
Clinical characteristics, treatment, and prognosis of lung cancer elderly patients Source: Eur Respir J 2001; 18: Suppl. 33, 228s Year: 2001
Chemotherapy improves low performance status lung cancer patients Source: Eur Respir J 2007; 30: 1186-1192 Year: 2007
Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy Source: Eur Respir J 2012; 39: 1437-1442 Year: 2012
Lung cancer: immunopathology Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=48 Year: 2001
Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013
Does diabetes mellitus influence the prognosis of patients with lung cancer? Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013
The effect of nutritional indicators on prognosis of patients with advanced lung cancer Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019
Clinical significance of serum cathepsin K level during chemotherapy of lung cancer. Can we use it as a marker of small cell lung cancer? Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008
A polymorphism, which exists intronic lesion of SLC5A10, affects DRG2 expression and survival outcome of early-stage non-small cell lung cancer Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015
Rhesus CE expression is an independent prognostic factor in non-small cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016
Surfactant protein-D level as a predictor of prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer Source: International Congress 2016 – Orphan diseases I Year: 2016
Attempting tissue diagnosis in performance status 3 and 4 lung cancer patients may not influence treatment or survival Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013
Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC) Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013
Prognostic factors affecting survival in cases with lung cancer [A lung cancer mapping project in Turkey (LCMPT)] Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013